Radhakrishnan, S. V., Bhardwaj, N., Steinbach, M., Weidner, J., Luetkens, T., & Atanackovic, D. (2017). Elotuzumab as a novel anti-myeloma immunotherapy. Hum Vaccin Immunother.
Chicago Style aipamenaRadhakrishnan, Sabarinath Venniyil, Neelam Bhardwaj, Mary Steinbach, Janet Weidner, Tim Luetkens, and Djordje Atanackovic. "Elotuzumab As a Novel Anti-myeloma Immunotherapy." Hum Vaccin Immunother 2017.
MLA aipamenaRadhakrishnan, Sabarinath Venniyil, et al. "Elotuzumab As a Novel Anti-myeloma Immunotherapy." Hum Vaccin Immunother 2017.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.